UC Receives $2 Million Gift to Benefit Pediatric Ophthalmology
The University of Cincinnati (UC) Academic Health Center has received a $2 million endowment to support research and education related to ophthalmic disorders of children.
The gift, from Ira A. Abrahamson Jr., MD, will establish the Ira A. Abrahamson, MD, Endowed Chair of Pediatric Ophthalmology (Abrahamson Chair) in UCs department of ophthalmology.
The Abrahamson Chair will be awarded to the director of the UC division of pediatric ophthalmology, who also will serve as director of pediatric ophthalmology at Cincinnati Childrens Hospital Medical Center.
The UCCincinnati Childrens programs work jointly in the diagnosis and treatment of retinoblastoma, the leading type of eye cancer in children.
The Abrahamson Chair will link UCs department of ophthalmology even more closely than before with the division of pediatric ophthalmology at Cincinnati Childrens, said James Augsburger, MD, chair of the UC ophthalmology department. Dr. Abrahamsons new gift will ensure continued expansion of pediatric ophthalmology at both institutions and improved eye care for all children in our region. We are thankful for Dr. Abrahamsons generosity and commitment.
Dr. Abrahamson is a 1948 graduate of UC College of Medicine and an emeritus faculty member in the ophthalmology department.
Funds from the Abrahamson endowment will be used within the UC pediatric ophthalmology division and at the Abrahamson Pediatric Eye Institute at Cincinnati Childrens, founded by Dr. Abrahamson in 1995.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.